3 × 3 model for drug use normalisation: Insights from a scoping review.

Ketelaars DTP, Karl AJ, Luijten M, Vink JM, Dijkstra BAG

Open source

DOI
10.1016/j.drugpo.2026.105251
Published
2026 Jun
Container
The International journal on drug policy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drugpo.2026.105251,
  title = {3 × 3 model for drug use normalisation: Insights from a scoping review.},
  author = {Ketelaars DTP and Karl AJ and Luijten M and Vink JM and Dijkstra BAG},
  year = {2026},
  journal = {The International journal on drug policy},
  doi = {10.1016/j.drugpo.2026.105251},
  url = {https://doi.org/10.1016/j.drugpo.2026.105251}
}

RIS

TY  - JOUR
TI  - 3 × 3 model for drug use normalisation: Insights from a scoping review.
AU  - Ketelaars DTP
AU  - Karl AJ
AU  - Luijten M
AU  - Vink JM
AU  - Dijkstra BAG
PY  - 2026
JO  - The International journal on drug policy
DO  - 10.1016/j.drugpo.2026.105251
UR  - https://doi.org/10.1016/j.drugpo.2026.105251
ER  - 

APA

DTP, K., AJ, K., M, L., JM, V., & BAG, D. (2026). 3 × 3 model for drug use normalisation: Insights from a scoping review.. The International journal on drug policy. https://doi.org/10.1016/j.drugpo.2026.105251

Source records